Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Reliant Pharmaceuticals
About
Reliant Pharmaceuticals provides cardiovascular pharmaceutical products.
- 501 - 1000
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $115M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Pharmaceutical
- Founded date
- Jan 1, 1999
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Reliant Pharmaceuticals provides cardiovascular pharmaceutical products. It is engaged in the sale and marketing of these products.Its product portfolio includes Axid, a nizatidin; InnoPran XL and DynaCirc CR for the treatment of hypertension; Omacor to reduce high triglycerides; and Rythmol SR.It provides products for the treatment of elevated cholesterol and triglycerides, acid reflux disease, and prevention of coronary complications in patients with coronary heart disease.It distributes its products to physicians engaged in primary care, cardiovascular, and specialized medical areas.Reliant Pharmaceuticals was established in 1999, headquartered in Liberty Corner, New Jersey.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2003 | Series D | $115M | 2 |
Invemed Catalyst Fund
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Invemed Catalyst Fund
|
Yes | Series D |
BayStar Capital
|
— | Series D |
